CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population

DNA and Cell Biology

Volumn 31, Issue 6, 2012, Pages 1107-1113

  Chen, Xiangmei ^a   Zhao, Tianshu ^b   Li, Li ^b   Xu, Chunhui ^a   Zhang, Xiaolei ^a   Tse, Vincent ^c   Zhang, Ting ^a   Liu, Xiaoqian ^b   Lu, Fengmin ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN D1A; CYCLIN D1B; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; BLOOD SAMPLING; CANCER RISK; CHINESE; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENOTYPE; GLIOMA; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; MALE; POPULATION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; WORLD HEALTH ORGANIZATION;

ADULT; AGE OF ONSET; ASIAN CONTINENTAL ANCESTRY GROUP; CYCLIN D1; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GLIOMA; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER;

EID: 84864037635     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1521     Document Type: Article

References (25)

1. Abramson, V.G., Troxel, A.B., Feldman, M., Mies, C., Wang, Y., Sherman, L., McNally, S., Diehl, A., and Demichele, A. (2010). Cyclin d1b in human breast carcinoma and coexpression with cyclin d1a is associated with poor outcome. Anticancer Res 30, 1279-1285.
2. Akkiz, H., Bayram, S., Bekar, A., Akgollu, E., and Ozdil, B. (2010). Cyclin d1 g870a polymorphism is associated with an increased risk of hepatocellular carcinoma in the turkish population: Case-control study. Cancer Epidemiol 34, 298-302.
3. Betticher, D.C., Thatcher, N., Altermatt, H.J., Hoban, P., Ryder, W.D., and Heighway, J. (1995). Alternate splicing produces a novel cyclin d1 transcript. Oncogene 11, 1005-1011.
4. Comstock, C.E., Augello, M.A., Benito, R.P., Karch, J., Tran, T.H., Utama, F.E., Tindall, E.A., Wang, Y., Burd, C.J., Groh, E.M., Hoang, H.N., Giles, G.G., Severi, G., Hayes, V.M., Henderson, B.E., Le Marchand, L., Kolonel, L.N., Haiman, C.A., Baffa, R., Gomella, L.G., Knudsen, E.S., Rui, H., Henshall, S.M., Sutherland, R.L., and Knudsen, K.E. (2009). Cyclin d1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer. Clin Cancer Res 15, 5338-5349.
5. Furnari, F.B., Fenton, T., Bachoo, R.M., Mukasa, A., Stommel, J.M., Stegh, A., Hahn, W.C., Ligon, K.L., Louis, D.N., Brennan, C., Chin, L., DePinho, R.A., and Cavenee, W.K. (2007). Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21, 2683-2710.
6. Gautschi, O., Ratschiller, D., Gugger, M., Betticher, D.C., and Heighway, J. (2007). Cyclin d1 in non-small cell lung cancer: a key driver of malignant transformation. Lung Cancer 55, 1-14.
7. Holley, S.L., Matthias, C., Jahnke, V., Fryer, A.A., Strange, R.C., and Hoban, P.R. (2005). Association of cyclin d1 polymorphism with increased susceptibility to oral squamous cell carcinoma. Oral Oncol 41, 156-160.
8. Holley, S.L., Parkes, G., Matthias, C., Bockmuhl, U., Jahnke, V., Leder, K., Strange, R.C., Fryer, A.A., and Hoban, P.R. (2001). Cyclin d1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck. Am J Pathol 159, 1917-1924.
9. Howe, D., and Lynas, C. (2001). The cyclin d1 alternative transcripts [a] and [b] are expressed in normal and malignant lymphocytes and their relative levels are influenced by the polymorphism at codon 241. Haematologica 86, 563-569.
10. Krieger, S., Gauduchon, J., Roussel, M., Troussard, X., and Sola, B. (2006). Relevance of cyclin d1b expression and ccnd1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma. BMC Cancer 6, 238.
11. Louis, D.N., Ohgaki, H., Wiestler, O.D., Cavenee, W.K., Burger, P.C., Jouvet, A., Scheithauer, B.W., and Kleihues, P. (2007). The 2007 who classification of tumours of the central nervous system. Acta Neuropathol 114, 97-109.
12. Lu, F., Gladden, A.B., and Diehl, J.A. (2003). An alternatively spliced cyclin d1 isoform, cyclin d1b, is a nuclear oncogene. Cancer Res 63, 7056-7061.
13. Millar, E.K., Dean, J.L., McNeil, C.M., OToole, S.A., Henshall, S.M., Tran, T., Lin, J., Quong, A., Comstock, C.E., Witkiewicz, A., Musgrove, E.A., Rui, H., Lemarchand, L., Setiawan, V.W., Haiman, C.A., Knudsen, K.E., Sutherland, R.L., and Knudsen, E.S. (2009). Cyclin d1b protein expression in breast cancer is independent of cyclin d1a and associated with poor disease outcome. Oncogene 28, 1812-1820.
14. Qiuling, S., Yuxin, Z., Suhua, Z., Cheng, X., Shuguang, L., and Fengsheng, H. (2003). Cyclin d1 gene polymorphism and susceptibility to lung cancer in a Chinese population. Carcinogenesis 24, 1499-1503.
15. Sawa, H., Ohshima, T.A., Ukita, H., Murakami, H., Chiba, Y., Kamada, H., Hara, M., and Saito, I. (1998). Alternatively spliced forms of cyclin d1 modulate entry into the cell cycle in an inverse manner. Oncogene 16, 1701-1712.
16. Shu, X.O., Moore, D.B., Cai, Q., Cheng, J., Wen, W., Pierce, L., Cai, H., Gao, Y.T., and Zheng, W. (2005). Association of cyclin d1 genotype with breast cancer risk and survival. Cancer Epidemiol Biomarkers Prev 14, 91-97.
17. Solomon, D.A., Wang, Y., Fox, S.R., Lambeck, T.C., Giesting, S., Lan, Z., Senderowicz, A.M., Conti, C.J., and Knudsen, E.S. (2003). Cyclin d1 splice variants. Differential effects on localization, rb phosphorylation, and cellular transformation. J Biol Chem 278, 30339-30347.
18. Stupp, R., Mason, W.P., van den Bent, M.J., Weller, M., Fisher, B., Taphoorn, M.J., Belanger, K., Brandes, A.A., Marosi, C., Bogdahn, U., Curschmann, J., Janzer, R.C., Ludwin, S.K., Gorlia, T., Allgeier, A., Lacombe, D., Cairncross, J.G., Eisenhauer, E., and Mirimanoff, R.O. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352, 987-996.
19. Wang, L., Habuchi, T., Mitsumori, K., Li, Z., Kamoto, T., Kinoshita, H., Tsuchiya, N., Sato, K., Ohyama, C., Nakamura, A., Ogawa, O., and Kato, T. (2003). Increased risk of prostate cancer associated with aa genotype of cyclin d1 gene a870g polymorphism. Int J Cancer 103, 116-120.
20. Wang, L., Habuchi, T., Takahashi, T., Mitsumori, K., Kamoto, T., Kakehi, Y., Kakinuma, H., Sato, K., Nakamura, A., Ogawa, O., and Kato, T. (2002). Cyclin d1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis 23, 257-264.
21. Wen, P.Y., and Kesari, S. (2008). Malignant gliomas in adults. N Engl J Med 359, 492-507.
22. Yang, S.X., Hewitt, S.M., Steinberg, S.M., Liewehr, D.J., and Swain, S.M. (2007). Expression levels of eif4e, vegf, and cyclin d1, and correlation of eif4e with vegf and cyclin d1 in multitumor tissue microarray. Oncol Rep 17, 281-287.
23. Yu, C., Lu, W., Tan, W., Xing, D., Liang, G., Miao, X., and Lin, D. (2003). Lack of association between ccnd1 g870a polymorphism and risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 12, 176.
24. Zhang, J., Li, Y., Wang, R., Wen, D., Sarbia, M., Kuang, G., Wu, M., Wei, L., He, M., Zhang, L., and Wang, S. (2003). Association of cyclin d1 (g870a) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population. Int J Cancer 105, 281-284.
25. Zhou, P., Jiang, W., Weghorst, C.M., and Weinstein, I.B. (1996). Overexpression of cyclin d1 enhances gene amplification. Cancer Res 56, 36-39.